Alyeska Investment Group, L.P. Kezar Life Sciences, Inc. Transaction History

Alyeska Investment Group, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$5.24 - $6.99 $1.05 Million - $1.4 Million	-200,000 Reduced 34.26%	383,831 $2.29 Million
Q4 2020 Feb 16, 2021	SELL	$4.77 - $6.58 $22,280 - $30,735	-4,671 Reduced 0.79%	583,831 $3.05 Million
Q2 2020 Aug 14, 2020	BUY	$3.6 - $7.75 $1.24 Million - $2.66 Million	343,383 Added 140.09%	588,502 $3.05 Million
Q1 2020 May 15, 2020	BUY	$2.77 - $5.75 $543,399 - $1.13 Million	196,173 Added 400.79%	245,119 $1.07 Million
Q2 2019 Aug 14, 2019	SELL	$7.09 - $21.9 $184,722 - $570,582	-26,054 Reduced 34.74%	48,946 $0
Q2 2018 Aug 14, 2018	BUY	$17.15 - $17.79 $1.29 Million - $1.33 Million	75,000 New	75,000 $1.3 Million

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.